Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > AnalytiscGPT Coming with Revenue generating Clients
View:
Post by PendleStock on Jul 17, 2023 11:06am

AnalytiscGPT Coming with Revenue generating Clients

The ideal scenario for Datametrex would be the successful launch of AnalyticsGPT, followed by the immediate acquisition of revenue-generating contracts once it is introduced to the market.That is very possible with the COO speaking of the high inteest their AI is generating during the Canadian AI Expo in S.Korea
Comment by Citron on Jul 17, 2023 12:01pm
The market isn't dreaming like you PendleStock and why it sits at multi year lows.
Comment by MarketMaestro on Jul 17, 2023 12:29pm
The first step would be to convert the businesses that participated in the Beta to the paid version of Analytics. Then add numbers to that. Although I would also prefer if they did not spin off their Medical division.
Comment by Aiking on Jul 17, 2023 1:36pm
Exactly, they definitely shouldn't spin off their medical vertical as it will become a cash cow and until now they only spend money on it. Don't spin it out as only insiders will profit. Us common shareholders will pay the insiders party (it was the same with Graph Blockchain years ago, or Screenpro. Insiders profit. Shareholders pay.
Comment by Forge24 on Jul 17, 2023 1:45pm
I understand the idea of your comparison however GBLC and Screenpro were not spin-offs so it's apples and oranges.  Shareholders will actually benefit from this spinoff, DM obviously sees big revs coming down the pipeline re; AI, or else they wouldn't be spinning off their soon to be most profitable division (especially once Vancouver and Ontario clinics are operational).    ...more  
Comment by Aiking on Jul 17, 2023 2:05pm
Although apples and oranges are fruits, and it's easy to compare it, I know what you mean. But I just don't see why spinning of a profitabel vertical would help to grow DM. Keep it, and the shareprice will rise too, as the revenue will be within DM stock and no other stock. I'm definitely against a spin off, as long as DM management doesn't make it plausible why it would be better ...more  
Comment by scottrose on Jul 17, 2023 1:55pm
I believe thats what happpening now converting beta clients and adding new verticals inside analytics. I would prefer they give us an update of whats happening.
Comment by Aiking on Jul 17, 2023 2:08pm
Exactyl an update on what's going on would be appreciated. And by the way the stock is it lowest since years. That justifies to do some off vacation communication to investors like us! At least this would show how DM management values their investors.
Comment by scottrose on Jul 17, 2023 2:46pm
Yes now would be a good time to hear the achievements they have made so far. Most of us are counting on analytics and the AI vertical to eventually replace the covid revs.
Comment by Aiking on Jul 17, 2023 4:41pm
Absolutely, they reported about their plans and timetable last time in March. Now over three months later would be a good and justified time to give an update on their projects within their three verticals. Also giving an outlook to what we can expect would be well appreciated.
Comment by PendleStock on Jul 18, 2023 11:27am
I think some of those SMEs who tried AnalyticsGPT during the beta test could pay for it if they were greatly impressed. Even 50% of the companies having a contract with Datametrex can be counted as a positive
Comment by RickyN on Jul 17, 2023 2:00pm
I also don't think a spinout is a good idea for us shareholders but Medi-call has had no revs something that would have been avoided if only good marketing IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities